Tous les communiqués de presse

- Valbiotis: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes.

Voir le communiqué de presse

- 2023 Semi-Annual Results (IN FRENCH).

Voir le communiqué de presse

- Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap.

Voir le communiqué de presse

- “Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups

Voir le communiqué de presse

- Valbiotis presents the full results of the Phase II/III REVERSE-IT study : impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes, a first for a non-drug active substance.

Voir le communiqué de presse

- First-half 2023 consolidated turnover (IN FRENCH).

Voir le communiqué de presse

- Deeptech start-up and mission oriented company, Oncosema is the winner of the I-LAB Innovation competition (IN FRENCH).

Voir le communiqué de presse

- Valbiotis announces the appointment of Charlotte JEZEQUEL as Director of Human Relations and Executive Committee member.

Voir le communiqué de presse

- Press Kit- The Limagrain wheat industry (IN FRENCH).

Voir le communiqué de presse

- METabolic EXplorer publishes its Sustainability 2022 report (IN FRENCH).

Voir le communiqué de presse